First Trust Direct Indexing’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-5,446
| Closed | -$1.33M | – | 718 |
|
|
2024
Q3 | $1.33M | Buy |
5,446
+568
| +12% | +$139K | 0.07% | 278 |
|
|
2024
Q2 | $934K | Buy |
4,878
+588
| +14% | +$113K | 0.06% | 326 |
|
|
2024
Q1 | $850K | Buy |
4,290
+505
| +13% | +$100K | 0.06% | 334 |
|
|
2023
Q4 | $651K | Buy |
3,785
+738
| +24% | +$127K | 0.06% | 372 |
|
|
2023
Q3 | $451K | Sell |
3,047
-299
| -9% | -$44.2K | 0.05% | 422 |
|
|
2023
Q2 | $731K | Buy |
3,346
+65
| +2% | +$14.2K | 0.08% | 296 |
|
|
2023
Q1 | $719K | Sell |
3,281
-65
| -2% | -$14.2K | 0.09% | 296 |
|
|
2022
Q4 | $696K | Sell |
3,346
-683
| -17% | -$142K | 0.09% | 287 |
|
|
2022
Q3 | $880K | Buy |
4,029
+587
| +17% | +$128K | 0.13% | 212 |
|
|
2022
Q2 | $722K | Buy |
3,442
+510
| +17% | +$107K | 0.1% | 266 |
|
|
2022
Q1 | $711K | Buy |
2,932
+206
| +8% | +$50K | 0.09% | 293 |
|
|
2021
Q4 | $710K | Buy |
2,726
+90
| +3% | +$23.4K | 0.09% | 274 |
|
|
2021
Q3 | $695K | Sell |
2,636
-183
| -6% | -$48.2K | 0.1% | 263 |
|
|
2021
Q2 | $695K | Buy |
2,819
+1,378
| +96% | +$340K | 0.1% | 256 |
|
|
2021
Q1 | $280K | Sell |
1,441
-86
| -6% | -$16.7K | 0.07% | 321 |
|
|
2020
Q4 | $325K | Buy |
+1,527
| New | +$325K | 0.09% | 278 |
|